Edition:
United Kingdom

Co-Diagnostics Inc (CODX.OQ)

CODX.OQ on NASDAQ Stock Exchange Capital Market

2.34USD
20 Feb 2018
Change (% chg)

$-0.21 (-8.24%)
Prev Close
$2.55
Open
$2.55
Day's High
$2.68
Day's Low
$2.26
Volume
18,628
Avg. Vol
9,534
52-wk High
$6.85
52-wk Low
$2.26

Chart for

About

Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $67.69
Shares Outstanding(Mil.): 11.92
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Co-Diagnostics Enters Into Lease For Upgraded Laboratory Facility In Salt Lake City

* CO-DIAGNOSTICS - ENTERS INTO LEASE FOR BIOLOGICAL SAFETY LEVEL 2 LABORATORY FACILITY IN SALT LAKE CITY, UTAH

19 Dec 2017

BRIEF-Co-Diagnostics to sign purchase agreement with Medcis Pathlabs

* Co-Diagnostics, Inc to sign purchase agreement with Medcis Pathlabs

05 Sep 2017

Earnings vs. Estimates

No consensus analysis data available.